Using MRI to assess changes in distribution and leakage of contrast media in murine mammary ducts after intra-ductal injection: intact ducts vs. ducts with in situ cancer
Erica Markiewicz1, Xiaobing Fan1, Devkumar Mustafi1, Marta Zamora1, Suzanne D. Conzen2, and Gregory S Karczmar1
1Radiology, University of Chicago, Chicago, IL, United States, 2Medicine, Hematology/Oncology, University of Chicago, Chicago, IL, United States
Contrast media injected directly into mammary
ducts clearly shows mammary gland structure with 3D-MRI. Development of in situ cancer causes changes in the leakage
rates and contrast agent distribution in ductal lumens and surrounding tissue. Differences
we describe here between FVB/N mice and the SV40Tag mammary cancer mouse model,
indicate that in situ cancer
significantly changes the permeability of the ductal epithelium. Information
gained from imaging these glands following intra-ductal injection can be used
to develop new MRI-detectable biomarkers for early detection of in situ cancer, improve understanding of
mammary cancer biology, and guide the design of new therapy.
This abstract and the presentation materials are available to members only;
a login is required.
